Edition:
United States

Theravance Biopharma Inc (TBPH.OQ)

TBPH.OQ on NASDAQ Stock Exchange Global Market

28.40USD
22 Oct 2018
Change (% chg)

-- (--)
Prev Close
$28.40
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
74,489
52-wk High
$35.48
52-wk Low
$21.27

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold -1.26 December 23 Oct 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 4 4 4 4
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 1 2 2 2
(5) SELL 1 1 1 1
No Opinion 0 0 0 0
Mean Rating 2.57 2.75 2.75 2.75

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 6 14.11 23.88 8.87 7.17
Quarter Ending Mar-19 2 15.46 21.50 9.43 --
Year Ending Dec-18 6 59.55 79.08 49.30 50.71
Year Ending Dec-19 6 80.76 105.00 44.99 69.12
Earnings (per share)
Quarter Ending Dec-18 6 -1.26 -1.11 -1.52 -1.07
Quarter Ending Mar-19 2 -1.13 -1.00 -1.26 --
Year Ending Dec-18 6 -4.38 -4.21 -4.70 -4.21
Year Ending Dec-19 6 -4.27 -3.72 -5.09 -4.27

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-18 10.67 23.48 12.81 120.08
Quarter Ending Mar-18 6.43 8.32 1.89 29.32
Quarter Ending Dec-17 4.84 4.51 0.33 6.77
Quarter Ending Sep-17 4.61 4.28 0.33 7.22
Quarter Ending Jun-17 4.66 3.51 1.15 24.74
Earnings (per share)
Quarter Ending Jun-18 -1.20 -0.76 0.44 -36.67
Quarter Ending Mar-18 -1.26 -1.22 0.04 -3.07
Quarter Ending Dec-17 -1.16 -1.64 0.48 -40.77
Quarter Ending Sep-17 -1.20 -1.12 0.08 -6.67
Quarter Ending Jun-17 -1.14 -1.27 0.13 -11.60

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 14.11 14.11 14.11 14.11 7.17
Quarter Ending Mar-19 15.46 15.46 15.46 15.46 --
Year Ending Dec-18 59.55 59.55 59.55 59.55 50.71
Year Ending Dec-19 80.76 80.76 80.97 80.97 69.12
Earnings (per share)
Quarter Ending Dec-18 -1.26 -1.26 -1.26 -1.26 -1.07
Quarter Ending Mar-19 -1.13 -1.13 -1.13 -1.13 --
Year Ending Dec-18 -4.38 -4.38 -4.38 -4.38 -4.21
Year Ending Dec-19 -4.27 -4.27 -4.10 -4.10 -4.27

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-18 0 0 0 0
Quarter Ending Mar-19 0 0 0 0
Year Ending Dec-18 0 0 0 0
Year Ending Dec-19 0 0 0 0
Earnings
Quarter Ending Dec-18 0 0 0 0
Quarter Ending Mar-19 0 0 0 0
Year Ending Dec-18 0 0 0 0
Year Ending Dec-19 0 0 0 0